201 related articles for article (PubMed ID: 18074436)
1. Editorial comment on: Prospective evaluation of quality of life in prostate cancer patients receiving combined treatment of postoperative radiotherapy plus androgen suppression for PT3 or positive resection margin after radical prostatectomy.
de Reijke TM
Eur Urol; 2007 Dec; 52(6):1650-1. PubMed ID: 18074436
[No Abstract] [Full Text] [Related]
2. Editorial comment on: Prospective evaluation of quality of life in prostate cancer patients receiving combined treatment of postoperative radiotherapy plus androgen suppression for PT3 or positive resection margin after radical prostatectomy.
Parker C
Eur Urol; 2007 Dec; 52(6):1651-2. PubMed ID: 18074437
[No Abstract] [Full Text] [Related]
3. Prospective evaluation of quality of life in prostate cancer patients receiving combined treatment of postoperative radiotherapy plus androgen suppression for PT3 or positive resection margin after radical prostatectomy.
Choo R; Pearce A; Danjoux C; Morton G; Deboer G; Szumacher E; Loblaw A; Cheung P
Eur Urol; 2007 Dec; 52(6):1645-50. PubMed ID: 17140722
[TBL] [Abstract][Full Text] [Related]
4. Prospective study evaluating postoperative radiotherapy plus 2-year androgen suppression for post-radical prostatectomy patients with pathologic T3 disease and/or positive surgical margins.
Choo R; Danjoux C; Gardner S; Morton G; Szumacher E; Loblaw DA; Cheung P; Pearse M
Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):407-12. PubMed ID: 19211197
[TBL] [Abstract][Full Text] [Related]
5. Two different perspectives in the management of pT3 and/or margin-positive prostate cancer after radical prostatectomy.
Choo R; Kawakami J; Siemens R; Davis BJ; Brundage M; Pisansky TM
BJU Int; 2006 Oct; 98(4):773-6. PubMed ID: 16978271
[No Abstract] [Full Text] [Related]
6. Pathological staging and biochemical recurrence after neoadjuvant androgen deprivation therapy in combination with radical prostatectomy in clinically localized prostate cancer.
Hennenfent BR
Br J Urol; 1998 Jul; 82(1):166. PubMed ID: 9698691
[No Abstract] [Full Text] [Related]
7. Postprostatectomy radiation therapy for prostate cancer.
Abramowitz MC; Pollack A
Semin Radiat Oncol; 2008 Jan; 18(1):15-22. PubMed ID: 18082584
[TBL] [Abstract][Full Text] [Related]
8. Long-term follow-up after triple treatment of prostate cancer stage pT3.
Schelin S; Madsen M; Palmqvist E; Mäkelä E; Klintenberg C; Aus G
Scand J Urol Nephrol; 2009; 43(3):186-91. PubMed ID: 19353383
[TBL] [Abstract][Full Text] [Related]
9. [Quality of life of patients with locally-advanced prostate cancer as a criterium of therapeutic effectiveness].
Kaprin AD; Kostin AA; Tsybul'skiĭ AD
Vopr Onkol; 2009; 55(3):285-90. PubMed ID: 19670727
[No Abstract] [Full Text] [Related]
10. Timing of androgen deprivation therapy and its impact on survival after radical prostatectomy: a matched cohort study.
Siddiqui SA; Boorjian SA; Inman B; Bagniewski S; Bergstralh EJ; Blute ML
J Urol; 2008 May; 179(5):1830-7; discussion 1837. PubMed ID: 18353378
[TBL] [Abstract][Full Text] [Related]
11. Need for high radiation dose (>or=70 gy) in early postoperative irradiation after radical prostatectomy: a single-institution analysis of 334 high-risk, node-negative patients.
Cozzarini C; Montorsi F; Fiorino C; Alongi F; Bolognesi A; Da Pozzo LF; Guazzoni G; Freschi M; Roscigno M; Scattoni V; Rigatti P; Di Muzio N
Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):966-74. PubMed ID: 19619960
[TBL] [Abstract][Full Text] [Related]
12. Editorial comment on: Time, symptom burden, androgen deprivation, and self-assessed quality of life after radical prostatectomy or watchful waiting: the Randomized Scandinavian Prostate Cancer Group Study Number 4 (SPCG-4) clinical trial.
Gattellari M; Ward JE
Eur Urol; 2009 Feb; 55(2):431. PubMed ID: 18783873
[No Abstract] [Full Text] [Related]
13. Definitive radiotherapy with adjuvant long-term antiandrogen treatment for locally advanced prostate cancer: health-related quality of life and hormonal changes.
Berg A; Dahl AA; Bruland ØS; Bjøro T; Aanensen MS; Fosså SD
Prostate Cancer Prostatic Dis; 2009; 12(3):269-76. PubMed ID: 19290019
[TBL] [Abstract][Full Text] [Related]
14. Quality of life and satisfaction with outcome among prostate-cancer survivors.
Yu JS; Roach M
N Engl J Med; 2008 Jul; 359(2):200; author reply 201-2. PubMed ID: 18614788
[No Abstract] [Full Text] [Related]
15. Testosterone recovery after prolonged androgen suppression in patients with prostate cancer.
Yoon FH; Gardner SL; Danjoux C; Morton G; Cheung P; Choo R
J Urol; 2008 Oct; 180(4):1438-43; discussion 1443-4. PubMed ID: 18710743
[TBL] [Abstract][Full Text] [Related]
16. Health-related quality of life 2 years after treatment with radical prostatectomy, prostate brachytherapy, or external beam radiotherapy in patients with clinically localized prostate cancer.
Ferrer M; Suárez JF; Guedea F; Fernández P; Macías V; Mariño A; Hervas A; Herruzo I; Ortiz MJ; Villavicencio H; Craven-Bratle J; Garin O; Aguiló F;
Int J Radiat Oncol Biol Phys; 2008 Oct; 72(2):421-32. PubMed ID: 18325680
[TBL] [Abstract][Full Text] [Related]
17. Editorial comment on: poor overall survival in septa- and octogenarian patients after radical prostatectomy and radiotherapy for prostate cancer: a population-based study of 6183 men.
Barry MJ
Eur Urol; 2008 Jul; 54(1):116-7. PubMed ID: 17996360
[No Abstract] [Full Text] [Related]
18. Time, symptom burden, androgen deprivation, and self-assessed quality of life after radical prostatectomy or watchful waiting: the Randomized Scandinavian Prostate Cancer Group Study Number 4 (SPCG-4) clinical trial.
Johansson E; Bill-Axelson A; Holmberg L; Onelöv E; Johansson JE; Steineck G;
Eur Urol; 2009 Feb; 55(2):422-30. PubMed ID: 18783877
[TBL] [Abstract][Full Text] [Related]
19. [Histopathologic changes due to combination of androgen deprivation and transurethral microwave thermotherapy in patients with localized prostate cancer].
Suzuki R; Jujo Y; Koshiba K; Hoshiai O; Endo T; Aihara M; Nakajo H; Ohori M
Hinyokika Kiyo; 2009 Feb; 55(2):79-85. PubMed ID: 19301612
[TBL] [Abstract][Full Text] [Related]
20. Health-related quality of life results in pathologic stage C prostate cancer from a Southwest Oncology Group trial comparing radical prostatectomy alone with radical prostatectomy plus radiation therapy.
Moinpour CM; Hayden KA; Unger JM; Thompson IM; Redman MW; Canby-Hagino ED; Higgins BA; Sullivan JW; Lemmon D; Breslin S; Crawford ED; Southwest Oncology Group
J Clin Oncol; 2008 Jan; 26(1):112-20. PubMed ID: 18165645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
